✦ LIBER ✦

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia

✍ Scribed by Sacchi, S; Kantarjian, H M; O’Brien, S; Beran, M; Koller, C; Pierce, S; Kornblau, S; Estey, E; Keating, M J; Talpaz, M

Book ID: 110053632
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 224 KB
Volume: 11
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2400791

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alpha-2c therapy of patients

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

✍ J. Thaler; G. Gastl; T. Fluckinger; D. Niederwieser; H. Huber; H. Seewann; H. Si 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 228 KB

Very long-term follow-up results of imat

Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

✍ Hagop Kantarjian; Susan O'Brien; Guillermo Garcia-Manero; Stefan Faderl; Farhad 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Long-term follow-up of alpha-interferon

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

✍ Monika van Zonneveld; Pieter Honkoop; Bettina E. Hansen; Hubertus G.M. Niesters; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Long-Term Follow-up of Allogeneic Bone M

Long-Term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase

✍ Shinichiro Okamoto; Reiko Watanabe; Satoshi Takahashi; Takehiko Mori; Tohru Izek 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 80 KB

Philadelphia chromosome-negative chronic

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long term follow-up results

✍ Jorge E. Cortes; Moshe Talpaz; Miloslav Beran; Susan M. O'Brien; Mary B. Rios; S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Background. Five to 10% of patients with chronic myelogenous leukemia (CML) do not have the Philadelphia chromosome (Ph), but one-third of them have rearrangements of the breakpoint cluster region (BCR-positive). Methods. The authors analyzed the characteristics, treatment response, and prognosis o

Sustained remissions and low rate of BCR

Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: A 5-year follow up

✍ Georg Hess; Ralf G. Meyer; Brigitte Schuch; Katja Bechthold; Ilse El-Kholy; Chri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 3 views